| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |